Results 111 to 120 of about 1,955 (161)
Some of the next articles are maybe not open access.
Dantrolene : From Malignant Hyperthermia to Alzheimer’s Disease
Dantrolene, a ryanodine receptor antagonist, is primarily known as the only clinically acceptable and effective treatment for Malignant Hyperthermia (MH).
Huafeng Wei
exaly +2 more sources
Dantrolene requires Mg 2+ to arrest malignant hyperthermia
Malignant hyperthermia (MH) is a clinical syndrome of skeletal muscle that presents as a hypermetabolic response to volatile anesthetic gases, where susceptible persons may develop lethally high body temperatures.
Xaver Koenig, Bradley Launikonis
exaly +3 more sources
Faced with a malignant hyperthermia crisis, the immediate access to sufficient dantrolene is essential to achieve the best possible outcome for the patient.
Stephan Johannsen, Thierry Girard
exaly +2 more sources
Anaesthesia, 1979
A single oral dose of dantrolene (100--150 mg) given at least 2 hr pre-operatively has been found to reduce significantly the strength of muscular fasciculations, the hyperkalaemia and the incidence of muscle pains following suxamethonium (from 56 to 4%) in a series of forty-eight patients compared with controls.
openaire +2 more sources
A single oral dose of dantrolene (100--150 mg) given at least 2 hr pre-operatively has been found to reduce significantly the strength of muscular fasciculations, the hyperkalaemia and the incidence of muscle pains following suxamethonium (from 56 to 4%) in a series of forty-eight patients compared with controls.
openaire +2 more sources
Hyperkalemia after Dantrolene and Verapamil-Dantrolene Administration in Dogs
Anesthesia & Analgesia, 1988The concurrent administration of dantrolene and verapamil has the theoretical advantage of being more efficacious than dantrolene alone in the treatment of malignant hyperthermia. However, the combination has been reported to cause fatal hyperkalemia in pigs.
A C, San Juan, K C, Wong, J D, Port
openaire +2 more sources

